Over the next few days, Dennis Gillings, a statistician who helped create the multibillion-dollar industry of conducting research studies for drug giants, is likely to enter an exclusive club: those with net worths above $1 billion. Quintiles , the largest clinical research organization and the company Gillings founded, will price an initial public offering on Thursday or Friday with an expected range between $36 and $40 per share. Gillings will own 25,062,181 shares, so his stake in Quintiles alone will be worth between $902 million and $1 billion. Ross Mulken, an analyst at International Strategy & Investing Group, an independent research firm, thinks shares could trade in the low 40s, which would put Gillings’ stake securely in billionaire territory.
The Next Billionaire: A Statistician Who Changed Medicine - Forbes
The Next Billionaire: A Statistician Who Changed Medicine - Forbes
Dislike ads? Remove them and support the forum:
Subscribe to Fastlane Insiders.